Outcomes in critically ill chronic lymphocytic leukemia patients. [electronic resource]
Producer: 20140526Description: 1885-91 p. digitalISSN:- 1433-7339
- Aged
- Alemtuzumab
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Female
- Hospital Mortality
- Humans
- Intensive Care Units
- Leukemia, Lymphocytic, Chronic, B-Cell -- therapy
- Logistic Models
- Male
- Middle Aged
- Prognosis
- Retrospective Studies
- Risk Factors
- Rituximab
- Treatment Outcome
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.